癌症患者在医院获得的血液感染:当前的知识和未来的方向
A MacPhail1, C Dendle2, M Slavin3
1School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Department of Infectious Diseases, Monash Health, Melbourne, Australia.
The Journal of hospital infection
|March 15, 2024
概括
患有癌症的患者面临更高的医院获得的血液感染 (haBSI) 和中枢线相关的血液感染 (CLABSI) 的风险. 标准化的监测和预防对于减少这种脆弱人群的伤害至关重要.
科学领域:
- 感染控制和医院流行病学
- 瘤学患者安全问题
- 公共卫生监督 公共卫生监督
背景情况:
- 与一般患者群体相比,癌症患者在医院获得的血液感染 (haBSI) 和中枢线相关的血液感染 (CLABSI) 的发生率更高.
- 现有的haBSI和CLABSI监测定义和策略并没有专门为癌症患者设计,这导致了临床实践的复杂性和变化.
- 由于这些复杂性,在癌症患者中获得关于haBSI和CLABSI的准确流行病学数据是具有挑战性的,可能会阻碍有效的干预策略.
研究的目的:
- 为癌症患者量身定制的haBSI和CLABSI监测和预防提供关键概念和挑战的概述.
- 总结当前癌症监测定义,分母和癌症护理实践的优缺点.
- 突出癌症患者的haBSI和CLABSI相关的流行病学,预防策略和知识差距.
主要方法:
- 对癌症患者的haBSI和CLABSI监测现有数据的文献综述和综合.
- 分析当前瘤监测定义和分类系统在瘤环境中的适用性和局限性.
- 审查当前的预防策略,并确定需要进一步研究的领域.
主要成果:
- 在癌症患者中应用标准haBSI和CLABSI定义是复杂的,临床实践和监测方法存在显著差异.
- 由于癌症患者的独特脆弱性和治疗复杂性,流行病学估计需要仔细解释.
- 通常使用的监测定义和分母在应用于癌症护理环境时具有不同的优缺点.
结论:
- 在全球范围内协调对癌症患者在医院获得的感染的监测,对于提高数据的准确性和有用性至关重要.
- 标准化方法对于推进预防工作和提高患有haBSI和CLABSI风险的癌症患者的患者安全至关重要.
- 通过合作努力解决当前的知识差距,将改善干预目标的识别,并减少可预防的伤害.
相关概念视频
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
4.2K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.2K
01:22Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K